Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IL24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCMR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCAMR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPKAPK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf116 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYRK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on